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Abbreviations: BAC: bile acid cocktail; BE: Barrett’s esophagus; [Ca2+]i intracellular Ca2+ 26 
concentration; CBE: Cl-/HCO3- exchanger; EECs: esophageal epithelial cells; GERD: 27 
gastroesophageal reflux disease; pHi: intracellular pH, NHE: Na+/H+ exchanger; NBC: 28 
Na+/HCO3- cotransporter; PAT-1: putative anion transporter-1; SE: squamous epithelium 29 
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ABSTRACT 51 
Barrett’s esophagus (BE) is considered to be the most severe complication of gastro-52 
esophageal reflux disease (GERD), in which the prolonged, repetitive episodes of combined 53 
acidic and biliary reflux result in the replacement of the squamous esophageal lining by 54 
columnar epithelium. Therefore, acid extruding mechanisms of esophageal epithelial cells 55 
(EECs) may play an important role in the defence. Our aim was to identify the presence of 56 
acid/base transporters on EECs and to investigate the effect of bile acids on their expressions 57 
and functions. Human EEC lines (CP-A and CP-D) was acutely exposed to bile acid cocktail 58 
(BAC) and the changes in intracellular pH (pHi) and Ca2+ concentration ([Ca2+]i) were 59 
measured by microfluorometry. mRNA and protein expression of ion transporters were 60 
investigated by RT-PCR, Western Blot and immunohistochemistry. We have identified the 61 
presence of Na+/H+ exchanger (NHE), Na+/HCO3- cotransporter (NBC) and a Cl- dependent 62 
HCO3- secretory mechanism in CP-A and CP-D cells. Acute administration of BAC 63 
stimulated HCO3- secretion in both cell lines and the NHE activity in CP-D cells by an IP3-64 
dependent calcium release. Chronic administration of BAC to EECs increased the expression 65 
of ion transporters compared to non-treated cells. Similar expression pattern was observed in 66 
biopsy samples from BE compared to normal epithelium. We have shown that acute 67 
administration of bile acids differently alters ion transport mechanisms of EECs, whereas 68 
chronic exposure to bile acids increases the expression of acid/base transporters. We speculate 69 
that these adaptive processes of EECs, represent an important mucosal defence against the 70 
bile acid-induced epithelial injury. 71 
 72 
Keywords: esophagus, epithelium, bile acids, ion transporters.73 
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INTRODUCTION  74 
Barrett’s esophagus (BE) is a premalignant condition of esophageal adenocarcinoma, 75 
characterized by the replacement of the normal squamous epithelium (SE) with a columnar, 76 
specialized intestinal type mucosa.(50) It is considered to be the most severe complication of 77 
gastro-esophageal reflux disease (GERD),(7, 20) in which the prolonged, long term, repetitive 78 
episodes of combined acidic and biliary reflux are thought to induce the development of a 79 
metaplastic mucosal lining in the esophagus.(44) By definition, esophageal columnar 80 
metaplasia is present if columnar lining can be observed above the esophagogastric junction 81 
(top of the gastric folds or distal end of esophageal palisade veins) during endoscopy. These 82 
metaplastic areas, however have a significant histological diversity. Although, specialized 83 
intestinal metaplasia is accepted most widely as the premalignant condition for esophageal 84 
adenocarcinoma, other histological structures – such as gastric, pancreatic or even ciliated 85 
metaplasias – are commonly present and subsequently they may also have a role in the 86 
timeline of the metaplasia – dysplasia – carcinoma sequence according to a rencent 87 
hypothesis.(36) Furthermore, both British and Montreal defintion of BE pay attention to the 88 
non-intestinal type esophageal metaplasias, dispite they have far less – if any – pontential for 89 
malignant transformation compared to specialized intestinal metaplasia.(64) 90 
 Several studies have established the harmful effects of both gastric and bile acids on 91 
the esophageal mucosa. (13, 40, 41, 47, 58, 63) Since they were also shown to promote cell 92 
differentiation and proliferation, their role in the development of columnar metaplasia and 93 
later esophageal adenocarcinoma is widely accepted. (10, 14, 22, 24, 30, 44, 45) However, the 94 
underlying mechanism by which metaplastic columnar epithelium then dysplasia and finally 95 
invasive cancer develops, is not completely understood yet.  96 
Several defensive mechanisms exist in esophageal epithelial cells (EECs) against the 97 
reflux-induced esophageal injury. One of the most important is the esophageal epithelial 98 
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resistance.(22, 38) It consists of functional and structural components such as, (i) surface 99 
mucus and unstirred water layers with HCO3- in it, which provides an alkaline environment, 100 
(ii) cell junctions (tight junctions) and transport proteins at the apical and basolateral 101 
membranes, which prevent the diffusion of H+ into the intercellular space and into the cell, 102 
respectively and (iii) intracellular buffering systems, such as HCO3- or phosphates buffering 103 
systems.(38, 39)  104 
The transport proteins on the apical and basolateral membranes of EECs play an 105 
important role in the epithelial defense mechanisms.(38, 39) At the apical membrane of EECs 106 
only a non-selective cation channel has been identified so far.(2) This channel is present in the 107 
SE of rabbits and has been shown equally permeable to Na+, Li+, K+ or even H+. The 108 
physiological role of this channel in esophageal epithelial function is poorly understood. 109 
Tobey et al. have shown that acidic pH inhibits channel activity so H+ can not enter the cell 110 
through this channel and therefore may represent a protective mechanism against luminal 111 
acidity.(57) Others suggest that this cation channel plays role in cell differentiation. Blockade 112 
of this channel by acidic pH may inhibit the replenishment of polarized epithelial cells from 113 
undifferentiated basal cells.(2)  114 
In contrast, at the basolateral membrane of SE several ion transporters have been 115 
identified. Tobey et al. have shown the presence of a Na+-dependent and Na+–independent, 116 
disulfonic stilbene-sensitive, Cl-/HCO3- exchangers (CBE) on cultured rabbit SE.(60, 61) The 117 
Na+-independent CBE mediates the efflux of HCO3- into the lumen, which results in the 118 
acidification of the intracellular pH (pHi). In contrast, the Na+-dependent CBE operates in a 119 
reverse mode and promotes the influx of HCO3- in exhange for intracellular Cl- and therefore 120 
contributes to the alkalisation of the cell.(60, 61) Beside the CBEs an amiloride-sensitive, 121 
Na+/H+ exchanger (NHE) has also been identified on the basolateral membrane of rat, rabbit 122 
and human SE.(29, 48, 59) Among the 9, known NHE isoforms, NHE1 has been shown to 123 
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present on EECs using reverse-transcription PCR (RT-PCR) and western-blot. The major role 124 
of NHE1 in the esophagus, is the regulation of pHi by the electroneutral exchange of 125 
intracellular H+ to extracellular Na+. In addition, NHE1 is also important in several defensive 126 
mechanisms such as cell volume regulation, proliferation and cell survival.(6, 10, 70)  127 
These studies have been performed on normal esophageal epithelium; however the 128 
activity or expression of these ion transporters in the columnar epithelia or under 129 
pathophysiological conditions is less characterized. Goldman et. al has recently shown that 130 
acute administration of bile acids dose-dependently decreases the pHi of human EECs derived 131 
from normal mucosa and BE.(15) This effect of bile acids is due to the activation of nitric 132 
oxide synthase which cause increased nitric oxide production that leads to the inhibition of 133 
NHE1 activity. Blockage of NHE1 results in extensive intracellular acidification and therefore 134 
DNA damage. Combination of bile acids at acidic pH caused a further decrease in pHi and 135 
resulted in a higher degree of DNA damage. It has also been shown that NHE1 is expressed at 136 
higher level in BE than in normal epithelium.(15) The DNA damaging effect of bile and acid 137 
have also been shown in normal esophageal cell line (HET1-A) which may participate in the 138 
development and progression of BE.(24)  139 
Ion transport processes highly contribute to luminal acid clearence mechanisms as 140 
well as esophageal tissue resistance, therefore the understanding of esophageal epithelial ion 141 
transport processes under physiological and pathophysiological conditions is of crucial 142 
importance. Ion transporters have been well characterized in SE but less in columnar 143 
epithelial cells; however, columnar epithelial cells play an essential role in the protection of 144 
the esophagus against further reflux-induced esophageal injury by the action of acid/base 145 
transporters. Therefore, our aims in this study were (i) to identify transport mechanisms in 146 
columnar epithelial cells derived from Barrett’s metaplasia (ii) to characterize the effect of 147 
main internal risk factors (such as HCl, bile acids) on the acid/base transporters and (iii) to 148 
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compare the mRNA and protein expression profile of acid/base transporters in human 149 
squamous and columnar epithelial cells obtained from normal esophageal mucosa and BE.  150 
 151 
MATERIALS AND METHODS 152 
 153 
Cell line 154 
CP-A human, non-dysplastic Barrett’s esophageal cell line was obtained from 155 
American Type Culture Collection. CP-D human, dysplastic Barrett’s cell line was kindly 156 
provided by Peter Rabinovich (University of Washington). Cells were maintained in MCDB-157 
153 medium supplemented with 5% fetal bovine serum, 4 mM L-glutamine, 0.4 µg/ml 158 
hydrocortisone, 20 mg/L adenine, 20 ng/ml recombinant human Epidermal Growth Factor, 159 
8.4 µg/L cholera toxin, 140 µg/ml Bovine Pituitary Extract, 1x ITS Supplement [5 µg/ml 160 
Insulin; 5 µg /ml Transferrin; 5 ng/ml Sodium Selenite]. Medium was replaced in every 2 161 
days and cells were seeded at 100% confluency. Cultures were continually incubated at 37 °C 162 
and gassed with the mixture of 5% CO2 and 95% air. Passage numbers between 20-30 were 163 
used in all experiment. 164 
 165 
Patients 166 
Fourteen patients with endoscopic evidence of esophageal metaplasia were enrolled in 167 
the First Department of Medicine, University of Szeged. Endoscopic procedures were carried 168 
out by standard, high resolution, white-light endoscopes (Olympus GIF-Q165) and the Prague 169 
C&M criteria were applied for the description of esophageal metaplasia.(49)  170 
Four biopsy samples were obtained from the macroscopically visible metaplastic 171 
columnar epithelium of the esophagus and an other four from the normal squamous lining. 172 
Two of each samples were formalin-fixed and submitted for histological evaluation including 173 
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immunohistochemistry. The remaining two samples were immediately placed and stored in 174 
RNA-later solution for real-time PCR analysis at -20°C. The patient details are shown in 175 
Table 1. All procedures were performed with informed patient consent and under approved 176 
human subject’s protocols from University of Szeged (No.: 2348).  177 
 178 
Chemicals and solutions 179 
General laboratory chemicals and bile acid salts were obtained from Sigma-Aldrich 180 
(Budapest, Hungary). 2,7-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester 181 
(BCECF-AM), 2-(6-(bis(carboxymethyl)amino)-5-(2-(2-(bis(carboxymethyl)amino)-5-182 
methylphenoxy)ethoxy)-2-benzofuranyl)-5-oxazolecarboxylic acetoxymethyl ester (Fura-2 183 
AM), 1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid (BAPTA-AM), 4,4'-184 
diisothiocyanatodihydrostilbene-2,2'-disulfonic acid, disodium salt (H2DIDS) were from 185 
Molecular Probes Inc (Eugene, OR). BCECF-AM (2 µmol/l) and BAPTA-AM (40 µmol/l) 186 
were prepared in dimethyl sulfoxide (DMSO), whereas FURA-2-AM (5 µmol/l) was 187 
dissolved in DMSO containing 20% pluronic acid. 4-isopropyl-3-methylsulphonylbenzoyl-188 
guanidin methanesulphonate (HOE-642) was provided by Sanofi Aventis (Frankfurt, 189 
Germany) and was dissolved in DMSO. Nigericin (10 mM) was prepared in ethanol and 190 
stored at -20 ºC.  191 
The compositions of the solutions used are shown in Table 2. Standard HEPES-192 
buffered solutions were gassed with 100% O2 and their pH was set to 7.4 with NaOH. 193 
Standard HCO3-/CO2-buffered solutions were gassed with 95% O2/5% CO2 to set pH to 7.4. 194 
All experiments were performed at 37 ºC. 195 
 196 
Measurment of intracellular pH and Ca2+ with microfluorimetry 197 
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150.000-250.000 cells were seeded to 24 mm cover slips which were mounted on the 198 
stage of an inverted fluorescence microscope linked to an Xcellence imaging system 199 
(Olympus, Budapest, Hungary). Cells were bathed with different solutions at 37oC at the 200 
perfusion rate of 5-6 ml/min. 6-7 cells/region of interests (ROIs) were examined in each 201 
experiments and one measurement per second was obtained. In order to estimate pHi cells 202 
were loaded with the pH-sensitive fluorescent dye, BCECF-AM for 20-30 min at room 203 
temperature. Cells were excited with 490 and 440 nm wavelengths, and the 490/440 204 
fluorescence emission ratio was measured at 535 nm. The calibration of the fluorescent 205 
emission ratio to pHi was performed with the high-K+-nigericin technique, as previously 206 
described.(19, 56) To determine the changes of intracellular Ca2+ concentration ([Ca2+]i) cells 207 
were incubated with FURA2-AM and pluronic acid for 50-60 min. For excitation, 340 and 208 
380 nm filters were used, and the changes in [Ca2+]i were calculated from the 340/380 209 
fluorescence ratio measured at 510 nm. 210 
 211 
Determination of buffering capacity and base efflux 212 
 The total buffering capacity (βtotal) of cells was estimated according to the NH4+ 213 
prepulse technique, as previously described.(18, 69) Briefly, EECs were exposed to various 214 
concentrations of NH4Cl in a Na+- and HCO3--free solutions. The total buffering capacity of 215 
the cells was calculated using the following equation: βtotal = βi + βHCO3- = βi + 2.3 x [HCO3-]i, 216 
where βi refers to the ability of intrinsic cellular components to buffer changes of pHi and was 217 
estimated by the Henderson–Hasselbach equation. βHCO3- is the buffering capacity of the 218 
HCO3-/CO2 system. The measured rates of pHi change (∆pH/∆t) were converted to 219 
transmembrane base flux J(B-) using the equation: J(B-)=∆pH/∆t x βtotal. The βtotal value at the 220 
start point pHi was used for the calculation of J(B-). We denote base influx as J(B) and base 221 
efflux (secretion) as -J(B-). 222 
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Measurment of the activity of Na+/H+ exchanger, Na+/HCO3- cotransporter and Cl-/ 223 
HCO3- anion exchanger 224 
In order to estimate the activity of NHEs, the Na+/HCO3- cotransporter (NBC) and 225 
CBE the NH4Cl prepulse technique was used. Briefly, exposure of esophageal cells to 20 mM 226 
NH4Cl for 3 min induced an immediate rise in pHi due to the rapid entry of lipophilic, basic 227 
NH3 into the cells. After the removal of NH4Cl, pHi rapidly decreased. This acidification is 228 
caused by the dissociation of intracellular NH4+ to H+ and NH3, followed by the diffusion of 229 
NH3 out of the cell. In standard Hepes-buffered solution the initial rate of pHi (ΔpH/Δt) 230 
recovery from the acid load (over the first 60 sec) reflects the activities of NHEs, whereas in 231 
HCO3-/CO2-buffered solutions represents the activities of both NHEs and NBC.(18) 232 
Two independent methods have been performed in order to estimate CBE activity . 233 
Using the NH4Cl prepulse technique the initial rate of pHi recovery from alkalosis in HCO3-234 
/CO2-buffered solutions was analyzed.(18) Previous data have indicated that under these 235 
conditions the recovery over the first 30 seconds reflects the activity of CBE.(18) The Cl- 236 
withdrawal technique was also applied, where removal of Cl- from the external solution 237 
causes an immediate and reversible alkalisation of the pHi due to the reverse operation of 238 
CBE under these conditions. Previous data have shown that the initial rate of alkalisation over 239 
the first 60 seconds reflects the activity of CBE.(66) 240 
In order to evaluate transmembrane base flux (J(B-)) the following equation was used: 241 
J(B-)= ΔpH/Δt X βtotal, where  ΔpH/Δt was calculated by linear regression analysis, whereas 242 
the total buffering capacity (βtotal) was estimated by the Henderson–Hasselbach equation using 243 
the following formula: βtotal = βi + βHCO3- = βi + 2.3x[HCO3-]i. We denote base influx as J(B) 244 
and base efflux (secretion) as -J(B-).(18, 69) 245 
 246 
Bile acid treatments 247 
 
 
11
In order to mimic the chronic bile acid exposure in GERD in vitro, cells were treated 248 
with bile acid cocktail (BAC) at pH 7.5 and 5.5. Two days prior to bile acids treatment, cells 249 
were seeded at 106 cells/75 cm2 tissue culture flasks and were grown to 70-80% of 250 
confluence. On the second day, after the seeding, cells were treated with bile acids for 10 min 251 
pulses, 3 times a day up to 7 days.(12) The compostion of BAC was: 170 µM glycocholic 252 
acid (GC), 125 µM glycochenodeoxycholic acid (GCDC), 100 µM deoxycholic acid (DC), 50 253 
µM glycodeoxycholic acid (GDC), 25 µM taurocholic acid (TC), 25 µM 254 
taurochenodeoxycholic acid (TCDC) and 8 µM taurodeoxycholic acid (TDC). The 255 
composition and concentration of BAC mimics the bile acid profile of GERD.(12, 26, 32) 256 
 257 
Quantitative real time PCR analysis 258 
Total RNA was purified from individual cell culture and biopsy samples using the 259 
RNA isolation kit of Macherey-Nagel (Nucleospin RNA II kit, Macherey-Nagel, Düren, 260 
Germany). All the preparation steps were carried out according to the manufacturer’s 261 
instructions. RNA samples were stored at –80oC in the presence 30 U of Prime RNAse 262 
inhibitor (Fermentas, Lithuania) for further analysis. The quantity of isolated RNA samples 263 
was checked by spectrophotometry (NanoDrop 3.1.0, Rockland, DE, USA).  264 
In order to monitor gene expression, quantitative real-time PCR (QRT-PCR) was 265 
performed on a RotorGene 3000 instrument (Corbett Research, Sydney, Australia) using the 266 
TaqMan probe sets of NHE1, NHE2, NBC and SLC26A6 genes (Applied Biosystems Foster 267 
City, CA, USA). 3 μg of total RNA was reverse transcribed using the High-Capacity cDNA 268 
Archive Kit (Applied Biosystems Foster City, CA, USA) according to the manufacturer’s 269 
instructions in final volume of 30 μL. The temperature profile of the reverse transcription was 270 
the following: 10 min at room temperature, 2 hours at 37 0C, 5 min on ice and finally 10 min 271 
at 75 0C for enzyme inactivation. These steps were carried out in a Thermal Cycler machine 272 
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(MJ Research Waltham, MA, USA). After dilution with 30 μL of water, 1 μL of the diluted 273 
reaction mix was used as template in the QRT- PCR. For all the reactions TaqMan Universal 274 
Master Mix (Applied Biosystems Foster City, CA, USA) were used according to the 275 
manufacturer’s instructions. Each reaction mixture (final volume: 20 μL) contained 1 μL of 276 
primer-TaqMan probe mix. The QRT-PCR reactions were carried out under the following 277 
conditions: 15 min at 95oC and 45 cycles of 95oC for 15 sec, 60oC for 1 min. Fluorescein dye 278 
(FAM) intensity was detected after each cycle. All of the samples were run in triplicates and 279 
non-template control sample was used for each PCR run to check the primer-dimer formation. 280 
The average CT value was calculated for each of the target genes (NHE1, NHE2, NBC and 281 
SLC26A6) and hypoxanthine-guanine phosphoribosyltransferase (HPRT) and the ΔCT was 282 
determined as the mean CT of the gene of interest minus the mean CT of HPRT.  283 
 In the case of cell lines, the relative changes in gene expression were determined using 284 
the ΔΔCT method as described in Applied Biosystems User Bulletin No. 2 (P/N 4303859). 285 
ΔΔCT was calculated using the following formula: ΔΔCT = ΔCT of treated cells – ΔCT of 286 
control, non-treated cells. The N-fold differential expression in the target gene was expressed 287 
as 2-ΔΔCT. Genes with expression values less than or equal to 0.5 were considered to be down-288 
regulated, whereas values higher than or equal to 2 were considered to be up-regulated. 289 
Values ranging from 0.51 to 1.99 were not considered to be significant.  290 
In the case of biopsy samples, the relative expression values of NHE1, NHE2, NBC 291 
and SLC26A6 in normal and BE samples was used to create box plots. In order to compare 292 
the expression of genes between normal and BE samples, Wilcoxon test was used. 293 
 294 
Western Blot analysis 295 
 Whole cell lysates were prepared as described previously.(25) Protein concentration of 296 
samples and bovine serum albumin standard was determined using the Bradford protein assay 297 
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(Bio-Rad Laboratories, Hercules, CA, USA). 30 μg of denatured protein was fractionated on a 298 
NuPAGE Bis-Tris 4–12% gel (Life Technologies, Carlsbad, CA, USA). Following 299 
electrotransfer, Immobilon-P membranes (Millipore, Billerica, MA, USA) were blocked with 300 
PBST containing 5% milk, followed by overnight incubation with the following primary 301 
antibodies: rabbit anti-NHE1 and -NHE2 (1:200, Alomone Laboratories, Jerusalem, Israel), 302 
rabbit anti-NBC (1:500, Abcam Cambridge, MA, USA), goat anti-Slc26a6 (1:200, Santa 303 
Cruz, Dallas, TX, USA) at 4 C. Mouse anti-GAPDH (1:10000 Merck Millipore) was used as 304 
an internal control. The secondary antibodies were all from Sigma-Aldrich and used at 305 
1:10000. Targeted proteins were visualized using a chemiluminescence detection system 306 
(Amersham ECL or ECL Prime; GE Healthcare Life Sciences, Pittsburgh, PA, USA) 307 
 308 
Immunohistochemistry 309 
Immunohistochemical analysis of NHE1 and NHE2 expressions was performed on 4% 310 
buffered, formalin-fixed sections of human esophageal biopsy samples (n=14) embedded in 311 
paraffin. The 5 µm thick sections were stained in an automated system (Autostain, Dako, 312 
Glostrup, Denmark). Briefly, the slides were deparaffinised, and endogenous peroxidase 313 
activity was blocked by incubation with 3% H2O2 (10 min). Antigenic sites were disclosed by 314 
applying citrate buffer in a pressure cooker (120 ºC, 3 min). To minimise non-specific 315 
background staining, the sections were then pre-incubated with milk (30 min). Subsequently, 316 
the sections were incubated with a mouse monoclonal anti-NHE1 (1:100 dilution, Abcam, 317 
Cambridge, UK) or chicken anti-NHE2 (1:50 dilution, Chemicon, Temecula, CA, USA). 318 
Primary antibodies exposed to LSAB2 labelling (Dako, Glostrup, Denmark) for 2 X 10 min. 319 
The immunoreactivity was visualised with 3,3’-diaminobenzidine (10 min); then the sections 320 
were dehydrated, mounted and examined. NHE1 and NHE2-containing cells were identified 321 
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by the presence of a dark-red/brown chromogen. The specificity of the primary antibodies 322 
was assessed by using mouse IgG1 or chicken IgY isotype controls. 323 
 324 
Statistical analysis 325 
Results are expressed as means (SEM) (n=6-7 cells/20–25 ROIs). Statistical analyses 326 
were performed using analysis of variance (ANOVA). p values ≤ 0.05 were accepted as 327 
significant. 328 
 329 
RESULTS 330 
 331 
pH regulatory mechanisms of human EECs 332 
In the first series of experiments, the resting pHi was determined. Cells were exposed 333 
to standard HEPES solution (pH 7.4), followed by a 5-minute exposure to a high 334 
K+/nigericin-Hepes solution at pH 7.28, 7.4 and 7.6. The classical linear model was used to 335 
determine the resting pHi of the cells.(19, 56) The resting pHi levels of CP-A and CP-D were 336 
7.32±0.03 and 7.31±0.03, respectively (data not shown). The resting pHi did not differ 337 
significantly among the pH experiments. 338 
In the next step, the major acid/base transporters of Barrett’s derived cells (CP-A and 339 
CP-D) was identified. NHE is an electroneutral transporter which mediates the efflux of H+ 340 
and influx of Na+ across the plasma membrane via the electrochemical Na+ gradient. Removal 341 
of Na+ from the standard Hepes-buffered solution resulted in a rapid intracellular acidification 342 
(Fig. 1A) in CP-A cells which is likely due to the blockade of NHE. The NH4Cl prepulse 343 
technique was also used to confirm the presence of NHE. Fig. 1B shows that administration of 344 
20 mM NH4Cl (3 min) in standard Hepes-buffered solution causes an immediate intracellular 345 
alkalization due to the rapid influx of NH3 into the cells. After the removal of NH4Cl from the 346 
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external solution the pHi dramatically decreases (due to the dissociation of NH4+) then returns 347 
to the baseline level. When Na+ was removed from the external solution the restoration of pHi 348 
was completely abolished. (Fig. 1B) Similar results were found in CP-D cells, which indicate 349 
that these cells also express functionally active NHE. So far, 9 NHE isoforms have been 350 
identified, all of which show different regulation and expression pattern in the human body. 351 
Functional measurements were performed to identify which isoforms are present in CP-A and 352 
CP-D cells. HOE-642 is a dose dependent isoform-selective inhibitor of NHE. At 1 µM, 353 
HOE-642 inhibits only NHE1, whereas at 50 µM inhibits both NHE1 and NHE2. Using the 354 
NH4Cl prepulse technique it was shown that 1 µM HOE-642 inhibited the recovery from acid 355 
load by 77.3 ± 3.0 % in CP-A and 70.0 ± 0.3 % in CP-D cells, whereas in the presence of 50 356 
µM HOE-642, the recovery was completely abolished in both cell lines. (Fig. 1C and D)  357 
NBC also plays a crucial role in pH regulation in several types of epithelial cells.(5, 358 
53, 62) NBC is an electrogenic transporter which mediates the influx of Na+ and HCO3- into 359 
the cells with a 1:2, Na+/HCO3- stoichiometry. In standard HCO3-/CO2-buffered extracellular 360 
solution, the pHi of CP-A cells rapidly decreased by the quick diffusion of CO2 into the 361 
cytoplasm. (Fig. 2A) A low level of pHi recovery was found after acidosis, which is probably 362 
due to the influx of HCO3- into the cells through NBC. Removal of Na+ resulted in the same 363 
level of acidification as in the standard Hepes-buffered solution. (Fig. 2A) In order to further 364 
confirm the presence of NBC, the effect of H2DIDS on the recovery from CO2-induced 365 
acidosis was investigated. H2DIDS is an inhibitor of both NBC and CBE. As seen on Fig. 2B, 366 
500 µM H2DIDS completely inhibited the regeneration from acidosis. However, after the 367 
removal of H2DIDS from the external solution, the pHi completely recovered. Since CBE did 368 
not affect the recovery from acidosis (see Fig. 2A), we hypothesize that a functionally active 369 
NBC is present in CP-A cells. Using the same experimental protocol, the presence of NBC 370 
was also confirmed in CP-D cells.  371 
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In order to estimate the activities of NHE and NBC, the effect of H2DIDS (500 µM) 372 
and HOE-642 (50 μM) on the recovery from acid load was tested separately and together. 373 
Both H2DIDS and HOE-642 equally reduced the recovery from acidosis, whereas combined 374 
administration of these two agents completely abolished it. (Fig. 2C and D) 375 
 Next we attempted to identify functionally active CBE. The activity of CBE was 376 
investigated by the Cl- removal technique in the presence and absence of HCO3-/CO2. In the 377 
absence of HCO3-, Cl- removal caused a very low level and reversible alkalization. (Fig. 3A) 378 
However, in standard HCO3-/CO2-buffered solution, significantly higher alkalization was 379 
observed, indicating the presence of a functionally active CBE on CP-A cells. (Fig. 3B) In 380 
case of CP-D cells, a marked alkalization was also observed after the removal of external Cl- 381 
in the presence of HCO3-/CO2, suggesting that these cells also possess CBE. 382 
 383 
Bile acids induce an intracellular acidification in CP-A cells 384 
In order to mimic the pathophysiological conditions in GERD, BAC was prepared 385 
using a mixture of 7 bile acids, as described in Materials and Methods.(12) The effect of BAC 386 
on the pHi of CP-A cells was tested under acidic (pH 5.5) and neutral (pH 7.5) conditions. At 387 
pH 7.5, 100 and 300 µM BAC had no effect on pHi, whereas at higher concentration (500 388 
µM), BAC caused a small acidification in CP-A cells.(0.1 ± 0.03; Fig. 4A) In contrast, at pH 389 
5.5, bile acids resulted in a dose-dependent, robust decrease in pHi (Fig. 4B). The pHi 390 
recovered to a variable degree during continued exposure to bile acids, whereas completely 391 
returned to the basal level after the removal of bile acids from the external solution. (Fig. 4A 392 
and B). In order to examine whether the effect of bile acids at pH 5.5 is a specific effect or 393 
only due to the low pH, the effect of acidic pH by itself on pHi was observed. Administration 394 
of Hepes-buffered solution at pH 5.5 induced a slight, reversible decrease in pHi (from 7.32 ± 395 
0.01 to 7.26 ± 0.01; Fig. 4D) indicating that although acid alone is able to decrease the pHi of 396 
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CP-A cells, in combination with bile acids induce a more robust intracellular acidification. 397 
The maximal pHi changes (ΔpHmax) are summarized on Fig. 4C and D. We have also 398 
investigated the rate (-J(B-)) at bile acids get into the cells (Fig. 4E and F). -J(B-) was 399 
calculated from the ΔpH/Δt obtained by linear regression analysis of pHi measurements made 400 
over the first 60 s after bile acid administration. Our results have shown that -J(B-) was much 401 
higher at pH 5.5 than pH 7.5. 402 
The effect of individual bile acids (100 μM each) on pHi was also tested. 403 
Administration of the non-conjugated DC resulted in the greatest pHi decrease compared to 404 
the other bile acids. (Fig. 4G) The effect of DC was twice as high under acidic than under 405 
neutral conditions. In contrast, conjugated bile acids had only a slight effect at pH 7.5, 406 
whereas induced a more pronounced acidification at pH 5.5 (Fig. 4G).  407 
 408 
Bile acids cause an IP3-mediated calcium signaling in CP-A cells 409 
 Since bile acids have ionophore properties,(33, 37) their effect on [Ca2+]i was 410 
investigated both under neutral and acidic conditions. At 100 and 300 µM concentrations, 411 
BAC had only a slight or no effect on [Ca2+]i. (Fig. 5A and B) Administration of acid by 412 
itself, also had only a marginal effect on [Ca2+]i. (Fig. 5D) In contrast, at 500 µM 413 
concentration bile acids induced a reversible increase in [Ca2+]i at pH 7.5, which was more 414 
pronounced at pH 5.5. (Fig. 5A and B).  415 
 Next the source of calcium release was identified. The effect of BAC on [Ca2+]i was 416 
examined either in the absence of external Ca2+ or in the presence of different inhibitors. 417 
Removal of Ca2+ from the extracellular solution slightly decreased the level of [Ca2+]i due to a 418 
certain degree of [Ca2+]i depletion. Under these conditions administration of 500 μM BAC, 419 
caused a slight increase in [Ca2+]i indicating that BAC induces calcium signalling from 420 
intracellular sources. (Fig. 5E) Next we attempted to identify the intracellular organellum 421 
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from which the calcium releases. Ruthenium red (RR) and caffeine are specific inhibitors of 422 
ryanodine (Ry) and inositol triphosphate (IP3) receptors, respectively, which mediate the 423 
release of calcium from endoplasmic reticulum (ER). 10 µM RR had no effect on BAC-424 
induced calcium release in calcium-free external solution. However, 20 mM caffeine 425 
completely blocked the effect of BAC on calcium signalling. The effect of BAC in the 426 
presence of gadolinium (Gd3+, 1μM), a plasma membrane Ca2+ channel inhibitor was also 427 
investigated. Administration of Gd3+ decreased the effect of 500 µM BAC on [Ca2+]i by 58.83 428 
± 1.3 % (Fig. 5E), indicating that beside the release of Ca2+ from intracellular sources, bile 429 
acids also induce the entry of extracellular Ca2+. 430 
 431 
Acute effect of bile acids on the activity of ion transporters in EECs 432 
 Next, the effect of BAC on the activity of acid/base transporters was examined using 433 
the NH4Cl prepulse technique. Administration of BAC dose-dependently decreased the 434 
recovery from acidosis in Hepes-buffered solution (Fig. 6A and B), indicating that bile acids 435 
inhibit the activity of NHE in CP-A cells. In order to determine which NHE isoform is 436 
involved in the inhibitory effect of bile acids, the effect of BAC was tested in the presence of 437 
the isoform-specific NHE inhibitor, HOE-642. 1 µM HOE-642 decreased the recovery from 438 
acidosis from 7.68 ± 1.11 to 1.78 ± 0.2. Administration of 500 µM BAC, in the continuous 439 
presence of 1 µM HOE-642, further decreased the acid recovery to 0.56 ± 0.09 (Fig. 6C) 440 
Since 500 µM BAC inhibited acid recovery by 77.15 ± 3.2%, and nearly 77% of the total 441 
NHE activity is due to NHE1, these results indicate that BAC remarkably inhibits NHE1 442 
however it also blocks NHE2 activity. 50 µM HOE-642 completely blocked the recovery 443 
from acidosis that was not affected by bile acids. 444 
 In HCO3-/CO2-buffered external solution, where both NHE and NBC are active, BAC 445 
caused a slighter decrease (42.56 ± 2.8% at 100 µM BAC, 47.09 ± 2.6% at 300 µM BAC and 446 
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50 ± 4.2% at 500 µM BAC; Fig. 6D and E) in CP-A cells, compared to Hepes-buffered 447 
solution. In order to evaluate the effects of bile acids on NBC alone NHE activity was 448 
completely blocked by the administration of 50 µM HOE-642. The NHE inhibitor decreased 449 
the acid recovery from 18.9 ± 2.47 to 7.85 ± 1.44 therefore the remaining recovery is due to 450 
NBC. Administration of 500 μM BAC in the continuous presence of HOE-642 increased the 451 
recovery to 14.88 ± 1.42 (Fig. 6F) suggesting that bile acids enhance the activity of NBC. 452 
 We have previously shown that the initial rate of recovery from alkalosis reflects the 453 
activity of CBE in the presence of HCO3-/CO2. Treatment of CP-A cells with BAC dose-454 
dependently increased the recovery from alkalosis (Fig. 6D and G), indicating that bile acids 455 
stimulate the HCO3- secretion of these cells. 456 
 The effect of BAC was also evaluated on CP-D cells. Bile acid treatment significantly 457 
increased the rate of acid recovery in Hepes-buffered solution (Fig. 6B) and the rate of acid 458 
and alkali recoveries in HCO3-/CO2-buffered solution (Fig. 6E and G), indicating that the 459 
activities of the major ion transporters are increased due to bile acid treatment. 460 
 Ca2+ plays an essential role in the function of several intracellular processes, therefore 461 
we examined whether the inhibitory/stimulatory effect of BAC on acid/base transporters is 462 
mediated by Ca2+. Pretreatment of the cells with the Ca2+ chelator BAPTA-AM, a significant 463 
decrease was obtained both in the inhibitory and stimulatory effects of 500 µM BAC on the 464 
ion transporters, indicating that the effects of bile acids on the acid/base transporters are 465 
calcium-dependent (data not shown). 466 
 467 
Chronic exposure of EECs to bile acids increase the expression of acid/base transporters 468 
 In the next step, the long term effect of bile acids was assessed under neutral and 469 
acidic conditions. CP-A and CP-D cells were grown to 70-80% confluency and treated with 470 
100 and 500 μM BAC at pH 7.5 and pH 5.5 as described in Materials and Methods. 7-days 471 
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treatment with BAC significantly increased the expression of NHE1, NHE2, NBC and an 472 
electrogenic CBE, putative anion transporter-1 (PAT-1 also known Slc26a6) compared to 473 
non-treated control cells at pH 7.5 in CP-A cells. (Fig. 7A) The expression of these ion 474 
transporters also increased in CP-D cells, however, significant changes were only detected in 475 
the case of NHE1 and NBC.(Fig. 7B) We have also performed these experiments under acidic 476 
(pH 5.5) conditions. In CP-A cells, at acidic pH alone or in combination with bile acids the 477 
expression levels of ion transporters did not change significantly (Fig. 7C) and a decrease in 478 
cell number was observed compared to the control groups. In contrast, CP-D cells displayed a 479 
significant increase in NHE1 levels after bile acid treatment at pH 5.5.(Fig. 7D) We have also 480 
shown that the enhanced mRNA levels of NHE1 were associated with significantly increased 481 
protein expression. (Fig. 7E) The Slc26a6 transporter expression also increased in CP-A cells 482 
at neutral pH (data not shown). These data are in accordance with our PCR results. However, 483 
in the case of NHE2 and NBC, there were no significant difference in the protein expression, 484 
between the control and the bile acid-treated group, at neutral pH (data not shown). 485 
 mRNA expression pattern of ion transporters was investigated in 14 pairs of normal 486 
squamous and BE biopsy samples obtained from patients with known BE. (Table 1) Using 487 
QRT-PCR, increased mRNA expressions of NHE1, NHE2, NBC and PAT-1 in BE were 488 
found both in intestinal (Fig. 8A) and non-intestinal (Fig. 8B) metaplasia compared to normal 489 
mucosa. The protein expression of NHE1 and NHE2 were also investigated by 490 
immunohistochemistry. Biopsy samples from both intestinal and non-intestinal metaplastic 491 
columnar mucosa but not from normal mucosa displayed strong membrane stainings against 492 
NHE1 and NHE2 antibodies (Fig. 8C).  493 
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DISCUSSION 494 
 495 
 Epithelial cells of the esophagus form a defensive wall against the toxic components 496 
of the refluxate. These cells reside in either stratified squamous or single lined columnar 497 
epithelium and protect the underlying tissue layers by various mechanisms. EECs provide 498 
esophageal epithelial resistance by the action of acid/base transporters which play an essential 499 
role in the maintenance of normal function of epithelial cells and therefore in the protection of 500 
the esophageal mucosa.  501 
 In this study, we have characterized the presence of ion transporters in Barrett’s 502 
specialized columnar epithelial cells and investigated the effects of the major component of 503 
the refluxate on the activity and expression of these ion transporters. Using functional and 504 
molecular biological techniques we have comfirmed the presence of two acid-extruding ion 505 
transporters, NHE and NBC and one acid-loading transporter, PAT-1 in EECs. The 506 
predominant NHE isoforms were NHE1 and NHE2 although the acid-extruding mechanism is 507 
rather attributable to NHE1. Furthermore, we have demonstrated that NHEs and NBC are 508 
equally involved in the alkalisation of EECs. We have provided evidence that Barrett’s cells 509 
possess PAT-1, a Cl-/HCO3- transporter which mediates the exchange of intracellular HCO3- 510 
to extracellular Cl- and therefore plays an important role in the acidification of the cells, 511 
however, other Cl-/HCO3- exchangers may also be involved in the pH regulation of these 512 
cells.  513 
 The major toxic factors in the refluxate are gastric acid and bile.(17, 23, 27, 31, 45, 52) 514 
We have demonstrated that bile acids induce intracellular acidosis in EECs and their effect 515 
was more pronounced under acidic condition, in accordance with previous findings in 516 
Barrett’s-derived and normal esophageal cell lines.(15) The administered mixture of bile acids 517 
was designed to mimic the bile acid composition of the refluxate under pathophysiological 518 
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conditions.(12, 26, 32), In accordance with the previous observations on mouse EECs only 519 
DC was shown to induce acidification at neutral conditions, and had the greatest effect at 520 
acidic pH among the seven bile acids investigated.(71) The solubility and therefore the 521 
toxicity of bile acids are mainly determined by their pKa value. The pKa value of non-522 
conjugated bile acids, such as DC, is between 5.2-6.2 therefore at neutral pH (7.5) they are 523 
mainly in a protonated, unsoluable form. However, at pH 5.5, unconjugated bile acids are less 524 
ionised, they can penetrate through the cell membrane and influence intracellular pathways. In 525 
contrast, conjugated bile acids have a lower pKa values: taurine conjugated bile acids have a 526 
pKa between 1.8 and 1.9 and glycine conjugated bile acids have a pKa between 4.3 and 527 
5.2.(34, 51) Therefore, at pH 5.5 and 7.5 most of these bile acids are still in ionised, inactive 528 
form which suggest that conjugated bile acids have smaller effect on cells than their non-529 
conjugated counterparts, under these conditions. Nevertheless, not only pKa value determines 530 
the effect of bile acids. Due to their detergent properties, bile acids are able to increase the 531 
permeability of the cell membrane to various ions which also contributes to their damaging 532 
effect.(23, 46) In addition, the acidic pH also promote the disruption of the plasma membrane, 533 
which further facilitates the entry of bile acids into the cells.(21) 534 
 Bile acids also induced a dose-dependent increase in [Ca2+]i. Similarly to the pH 535 
measurements, the effect of bile acids was more robust under acidic conditions. These 536 
findings were in agreement with observations of other laboratories that demonstrated that 537 
exposure to DC or acidic media induced intracellular Ca2+ elevation in CP-A cells (14, 30) 538 
and mouse EECs.(71) It has also been shown that caffeine, an inhibitor of IP3-mediated Ca2+ 539 
responses, completely inhibited the bile acid-induced Ca2+ signalling in the absence of 540 
extracellular Ca2+, suggesting the involvement of IP3 receptors in the bile acid-induced 541 
calcium release. Similar mechanisms have been described in colonic crypt, hepatocytes or 542 
pancreatic duct and acini. (3, 8, 11, 42, 66, 67) Gadolinium, a known inhibitor of plasma 543 
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membrane Ca2+ entry channels, strongly blocked the bile acid induced Ca2+ signalling 544 
indicating that bile acids also promote the influx of extracellular calcium. The exact 545 
mechanism by which bile acids induce the entry of extracellular Ca2+ is not known. In rat 546 
hepatocytes, bile acids directly stimulate store-operated Ca2+ channels on the plasma 547 
membrane;(1) however further investigations are necessary to identify those Ca2+ channels 548 
that contribute to the effect of bile acids on the esophagus.  549 
 Acute effect of bile acids. Since the protective role of columnar epithelial cells highly 550 
depends on the normal function of acid/base transporters, we investigated, the effects of bile 551 
acids on the activity of the previously characterized ion transporters. Administration of BAC, 552 
dose-dependently decreased the activity of NHEs (both NHE1 and NHE2), whereas 553 
stimulated the activities of NBC and PAT-1 in CP-A cells. Inhibition of NHEs probably 554 
contributes to the acidification of the CP-A cells. In contrast, the acidification and 555 
consequently the cell death can be prevented by the increased activity of the HCO3- import 556 
system through the NBC. In addition, the efflux of HCO3- through the Cl-/HCO3- exchanger, 557 
PAT-1 also plays an important role in the protection of the cells, by the neutralization of the 558 
cell environment in the surface mucus layer. The increased activities of NBC and PAT-1 559 
probably compensate the decreased NHE activity and therefore try to maintain the acid/base 560 
equilibrium of the cell.  561 
 Interestingly, we found that NHE activity was stimulated in CP-D cells after bile acid 562 
treatment. This difference to CP-A cells can be explained by the advanced stage of CP-D 563 
cells. It has been described earlier that dysplastic Barrett’s mucosa has more severe and 564 
prolonged acidic and biliary reflux exposure.(41) Furthermore, it has also been observed that 565 
CP-D cells are more resistant to GERD-like stimuli compared to CP-A cells.(28) The 566 
mechanism for this alteration and its potential physiological role cannot be explained by the 567 
present studies and is an area of focus for future work. 568 
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 The underlying mechanism by which bile acids exert their stimulatory/inhibitory 569 
effects has also been investigated. Previous studies have demonstrated that the effect of bile 570 
acids on ion transporters is mediated by transient elevation of [Ca2+]i.(42, 66) Our results have 571 
shown that chelation of [Ca2+]i by BAPTA-AM almost completely abolished both the 572 
inhibitory and stimulatory effect of BAC on ion transporters. Although, we have not studied 573 
the mechanism by which Ca2+ mediate the effect of bile acids on CP-A cells, we propose that 574 
the activation of PAT-1 is connected to the activation of Ca2+-activated ion channels, such as 575 
Ca2+-activated Cl- channels or K+ channels, as demonstrated in other epithelia.(35, 65, 72) In 576 
contrast to PAT-1, high levels of [Ca2+]i strongly inhibited NHE activity. Previous studies on 577 
rabbit ileal brush-border membrane and renal NHE containing proteoliposomes have 578 
demonstrated that the phosphorylation of specific proteins by the Ca2+/calmodulin cascade 579 
results in a robust blockade of NHE.(9, 68) Taken together these data indicate that the 580 
increased levels of Ca2+ probably do not directly modulates the activity of ion transporters; 581 
however further investigations are needed to identify those intracellular signalling pathways 582 
or molecules which are involved in this process.  583 
 Chronic effect of bile acids. Beside the investigation of the acute effect of bile acids, 584 
we also studied the expression profile of ion transporters after chronic exposure to bile acids. 585 
7-days treatment with bile acids increased the mRNA expression of all of the investigated 586 
transporters in CP-A cells and the mRNA expression of NHE1 and NBC in CP-D cells, at 587 
neutral pH. In contrast, the expression of the transporters did not change significantly under 588 
acidic conditions in CP-A cells, moreover, the cell number dramatically decreased. In 589 
contrast, the expression of NHE1 significantly increased in CP-D cells at pH 5.5. We could 590 
also confirm the increased expression of NHE1 at protein level. We speculate that the 591 
overexpression of ion transporters is probably a defensive or adaptive mechanism by which 592 
the cells try to compensate the toxic, acidifying effect of bile acids. 593 
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 In order to extend our study, we also investigated the mRNA expression of ion 594 
transporters in biopsy samples obtained from normal squamous and different types of 595 
columnar metaplastic mucosa. In Europe, BE is characterized by the presence of 596 
macroscopically visible metaplastic columnar epithelium.(55) In contrast, in the USA only the 597 
intestinal type of metaplasia is considered to be BE.(43) Thus, we divided our samples into 598 
intestinal and non- intestinal groups and analyzed them separately. NHEs, NBC and PAT-1 599 
displayed higher mRNA levels in both intestinal and non-intestinal metaplasia compared to 600 
normal tissue. Increased protein expression of NHE1 and NHE2 were also confirmed in BE. 601 
These results are consistent with the report by Goldman et al., that demonstrated upregulation 602 
of NHE-1 in BE compared to normal epithelium both at mRNA and protein levels in biopsy 603 
samples and cell lines.(15) Similarly to findings of other laboratories in various tissues, we 604 
observed strong apical staining for NHE-2.(4, 16, 54) 605 
Our data indicate that the metaplastic columnar tissue is adapted better to the acidic 606 
environment, compared to the normal epithelium. Firstly, BE has a much higher capacity for 607 
HCO3- secretion through the luminal CBE. Since HCO3- effectively neutralizes the acidic 608 
chyme, which arises during the backward diffusion of gastric content, metaplastic tissue is 609 
more resistant against the injurious agents. Secondly, the proton extruding (NHEs) and HCO3- 610 
loading (NBC) transporters are highly up-regulated in BE which also present an effective, 611 
protective mechanism against cellular acidification. 612 
 Taken together, we have shown that exposure of columnar esophageal cells to bile 613 
acids induce a cellular acidification. Although, we did not investigate the exact mechanism, 614 
we speculate that the Ca2+ dependent inhibition of NHE is likely to contribute in this process. 615 
Prolonged exposure of columnar cells to bile acids increases the expression of acid/base 616 
transporters and we showed that bile acids by themselves are less toxic than in combination 617 
with acid. Moreover, we found that the major acid/base transporters are over expressed in BE 618 
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tissue, indicating that the metaplastic tissue is adapted better to the injurious environment 619 
providing more effective protection to the underlying layers.  620 
 We suspect that altered activities and expression of ion transporters after bile acid 621 
exposure are part of an early adaptive process of EECs. Our findings may help to better 622 
understand the esophageal response to injury and the role of ion transporters in this process. 623 
We believe that pharmacological activation of ion transporters increases epithelial resistance 624 
in acidic environment and therefore may protect the esophageal mucosa against the injurious 625 
bile acids. 626 
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FIGURE LEGENDS 913 
 914 
Figure 1. Investigation of Na+/H+ exchanger (NHE) activity on esophageal epithelial cells 915 
(EECs). (A) Removal of Na+ from the standard Hepes solution caused a rapid and marked 916 
intracellular acidosis in CP-A cells which confirms the presence of a Na+-dependent H+ efflux 917 
mechanism. (B) Recovery from acid load reflects the activity of NHE in standard Hepes-918 
buffered solution. In the case of the second NH4Cl pulse, Na+ was removed from the external 919 
solution 10 min before the pulse started, during the NH4Cl pulse and 10 min after the pulse. 920 
(C) Representative pHi curve shows the recovery from acid load in the presence of 1 and 50 921 
µM HOE-642. (D) Summary data of the calculated activities of the different NHE isoforms in 922 
the presence of isoform selective NHE inhibitor, HOE-642. The rate of acid recovery (J(B-)) 923 
was calculated from the ΔpH/Δt obtained by linear regression analysis of pHi measurments 924 
made over the first 60 s of recovery from the lowest pHi level (start point pHi). The buffering 925 
capacity at the start point pHi was used for the calculation of J(B-). Data are presented as 926 
means ± SEM. * : p≤ 0.05 vs. Control. n=15-25. N.D.: not detected. 927 
 928 
Figure 2. Investigation of Na+/HCO3- cotransporter (NBC) activity on esophageal 929 
epithelial cells (EECs). (A) Representative pHi curve showing the effect of Na+ removal on 930 
CP-A cells in HCO3-/CO2-buffered solution. (B) Administration of 500 μM H2DIDS 931 
completely abolished the recovery from acidosis in CP-A cells. (C) Representative pHi traces 932 
showing the effect of H2DIDS (500 μM) and HOE-642 (1 μM) on the recovery from acidosis 933 
in HCO3-/CO2-buffered solution. CP-A cells were acid loaded twice. The first NH4Cl pulse 934 
was the control and the second was the test. H2DIDS/HOE-642 was added 1 min before the 935 
end of NH4Cl pulse and further 2 min after the pulse. (D) Summary data of the calculated 936 
NHE and NBC activities. The rate of acid recovery (J(B-)) was calculated as described in 937 
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Figure 1. * : p≤ 0.05 vs. Control. Data are presented as means ± SEM. n=15-25. N.D.: not 938 
detected. 939 
 940 
Figure 3. Investigation of Cl-/HCO3- exchanger (CBE) activity on CP-A cells. The activity 941 
of CBE was investigated by the Cl- removal technique in the presence and absence of HCO3-942 
/CO2. In standard Hepes-buffered solution (A), removal of Cl- (5 min) had no significant 943 
effect on pHi. However, in standard HCO3-/CO2 solution (B), the steady state pHi in the 944 
absence of Cl- significantly increased, indicating the presence of a functionally active CBE on 945 
CP-A cells. 946 
 947 
Figure 4. Effect of bile acids on the intracellular pH (pHi) of CP-A cells. CP-A cells were 948 
exposed to 100, 300 and 500 µM bile acid cocktail (BAC) for 5 min at (A) pH 7.5 and (B) pH 949 
5.5. Summary data for the maximal pHi change (ΔpHmax) at pH 7.5 (C) and pH 5.5 (D) and 950 
the calculated base flux (-J(B-) induced by BAC (E and F). -J(B-) was calculated from the 951 
ΔpH/Δt obtained by linear regression analysis of pHi measurements made over the first 60 s 952 
after bile acid administration. The start point pHi for the measurment of ΔpH/Δt was the pHi 953 
immediately before exposure to bile acids. The buffering capacity at the start point pHi was 954 
used for the calculation of -J(B-). (G) Effect of individual bile acids (100 µM each) on 955 
ΔpHmax at at pH 7.5 (black column) and pH 5.5 (empty column). Data are presented as means 956 
± SEM. n=15-25. N.D.: not detected. DC: deoxycholic acid, TC: taurocholic acid, TDC: 957 
taurodeoxycholic acid, GC: glycocholic acid, GDC: glycodeoxycholic acid, GCDC: 958 
glycochenodeoxycholic acid, TCDC: taurochenodeoxycholic acid.  959 
 960 
Figure 5. Effect of bile acids on intracellular Ca2+ concentration [Ca2+]i of CP-A cells. 961 
Representative experimental traces showing the effect of 100, 300 and 500 µM bile acid 962 
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cocktail (BAC) at pH 7.5 (A) and pH 5.5 (B) on [Ca2+]i. Summary data of the bile acids-963 
induced [Ca2+]i changes at pH 7.5 (C) and pH 5.5 (D). Values are expressed as percent of 964 
basal [Ca2+]i. (E) Effect of extracellular Ca2+ removal, caffeine (20 mM), ruthenium red (10 965 
µM) and gadolinium (1μM) on the rise in [Ca2+]i induced by 500 µM BAC. All experiments 966 
were performed in HEPES-buffered solution. Data are presented as means ± SEM. * : p≤ 0.05 967 
vs. 500 µM BAC. n = 10-21.  968 
 969 
Figure 6. Effects of bile acids on acid/base transporters on esophageal epithelial cells 970 
(EECs). (A) Representative pHi traces show the effect of 100, 300 and 500 µM bile acid 971 
cocktail (BAC) in Hepes-buffered solution on the CP-A cell line. Cells were treated with bile 972 
acids 3 min before the pulse started, during the NH4Cl pulse and 3 min after the pulse. (B) 973 
Summary of the calculated Na+/H+ exchanger (NHE) activity in CP-A and CP-D cells. The 974 
rate of acid recovery (J(B-)) was calculated as described in Figure 1. (C) Summary of the 975 
effect of 500 μM BAC on the activities of different NHE isoforms in CP-A cells in the 976 
presence of 1 and 50 μM HOE-642. (D) Representative pHi traces show the effect of 100, 300 977 
and 500 µM bile acid cocktail (BAC) in HCO3-/CO2 -buffered solution on the CP-A cell line. 978 
Cells were treated with bile acids 3 min before the pulse started, during the NH4Cl pulse and 3 979 
min after the pulse. (E) Summary of the calculated NHE and Na+/HCO3- cotransporter (NBC) 980 
activities in CP-A and CP-D cells. The rate of acid recovery (J(B-)) was calculated as 981 
described in Figure 1. (F) Summary data of the calculated rates of pHi recovery from acid 982 
load in HCO3-/CO2- buffered solution in CP-A cells. The effect of bile acids on NBC activity 983 
was evaluated in the presence of 50 μM HOE-642. The rate of acid recovery (J(B-)) was 984 
calculated as described in Figure 1. (G) Summary of the calculated Cl-/HCO3- exchanger 985 
activity in CP-A and CP-D cells. The rate of alkali recovery (-J(B-)) was calculated from the 986 
ΔpH/Δt obtained by linear regression analysis of pHi measurements made over the first 30 s 987 
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of recovery from the highest pHi level (start point pHi). The buffering capacity at the start 988 
point pHi was used for the calculation of J(B-). Data are presented as means ± SEM.*: p≤ 0.05 989 
vs. Control. n=15-25.  990 
 991 
Figure 7. Expression of ion transporters in Barrett’s cell lines. CP-A and CP-D cells were 992 
treated with different bile acids for 7 days at pH 7.5 (A and B) and 5.5 (C and D) and the 993 
relative mRNA expressions of NHE1, NHE2, NBC and SLC26A6 were investigated by real-994 
time PCR. Data are presented as means ± SEM. (E) Western Blot analysis for NHE1 protein 995 
expression after 100 and 500 μM bile acid treatments. BAC: bile acid cocktail. 996 
 997 
Figure 8. Expression of ion transporters in human esophageal biopsy samples. Box plots 998 
are showing the relative expression of NHE1, NHE2, NBC and SLC26A6 in biopsy samples 999 
derived from intestinal (A) and non-intestinal (B) metaplasia. Median values are shown as a 1000 
horizontal black bar within each box. *:p≤ 0.05 vs. normal squamous epithelium. n=7. (C) 1001 
Representative pictures show immunohistochemical staining of NHE1 and NHE2 in normal 1002 
esophageal squamous mucosa and intestinal metaplastic tissue specimens. Isotype negative 1003 
control (NC) was also included to assess non-specific staining. Scale bar represent 50 μm. 1004 
SQ: squamous mucosa, M: metaplasia. Arrows pointing toward NHE-1 and NHE-2 staining. 1005 
 1006 
Table 1. Patient details. The lengths of metaplasia are given according to the Prague C&M 1007 
criteria. 1008 
Table 2. Composition of solutions. Values are in mM.  1009 
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Table 1. 
Patient 
No. 
Gender Age Type of 
metaplasia 
Length of 
metaplasia 
1. Male 82 Intestinal c0m3 
2. Male 76 Intestinal c3m4 
3. Male 57 Intestinal c2m4 
4. Male  49 Intestinal c3m4 
5. Female 70 Intestinal c1.5m5 
6. Female 65 Intestinal c8m10 
7. Female 62 Intestinal c1m3 
8. Male 47 Non-intestinal c1m1 
9. Female 81 Non-intestinal c1m2 
10. Female 61 Non-intestinal c0m1.5 
11. Female 58 Non-intestinal c0m1 
12. Female 56 Non-intestinal c0m1 
13. Female 55 Non-intestinal c0m1 
14. Female 50 Non-intestinal c0m0.5 
Table 2. 
Standard 
Hepes 
Standard 
HCO3
- 
NH4Cl 
Hepes 
NH4Cl 
HCO3
- 
 
Na+-free 
Hepes 
Cl--free 
Hepes 
Cl--free 
HCO3
- 
NaCl 130 115 110 95 
KCl 5 5 5 5 5 
MgCl2 1 1 1 1 1 
CaCl2 1 1 1 1 1 
Na-Hepes 10 10 
Glucose 10 10 10 10 10 10 10 
NaHCO3 25 25 25 
NH4Cl 20 20 
Hepes 10 
NMDG-Cl 10 
Na-
gluconate 
140 140 115 
Mg-
gluconate 
1 1 
Ca-
gluconate 
6 6 
K-sulfate 5 2.5 
